ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2019

Jun 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2019-05-31

Reporting Person: Myszkowski Kenneth Allen (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-31	Common Stock	M	15000	$4.60	Acquired	293536	Direct
2019-05-31	Common Stock	M	20000	$5.19	Acquired	313536	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-31	Stock Option (right to buy)	$4.60	M	15000	Disposed	2021-10-21	Common Stock (15000)	Direct
2019-05-31	Stock Option (right to buy)	$5.19	M	20000	Disposed	2022-02-16	Common Stock (20000)	Direct

Footnotes

F1: Represents first vesting date. Option vested over four years from date of grant.